Natalia Ramírez-Merino
- Oncology top 10%
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
- PARP inhibition in cancer therapy 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
-
- DNA Repair Mechanisms 2
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Clinical practice guidelines implementation 1
-
- BRCA gene mutations in cancer 1
- Co-authors
- Federico RojoPîlar ErolesJoan AlbanellSònia ServitjaJetzabel García-ParraJaime Ferrer-LozanoJosé YélamosSandra Zazo
- Cited by
- OncologyCancer ResearchSurgery
- Journals
- International Journal of Molecular Sciences (1 paper)Annals of Oncology (2 papers)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- SpainPalestinian TerritoryUnited Kingdom
In The Last Decade
Natalia Ramírez-Merino
7 papers receiving 357 citations
Peers
Comparison fields: 5 of 63
- Oncology 236
- Cancer Research 60
- Surgery 107
- Molecular Biology 160
- Pulmonary and Respiratory Medicine 72
Countries citing papers authored by Natalia Ramírez-Merino
This map shows the geographic impact of Natalia Ramírez-Merino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Ramírez-Merino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Ramírez-Merino more than expected).
Fields of papers citing papers by Natalia Ramírez-Merino
This network shows the impact of papers produced by Natalia Ramírez-Merino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Ramírez-Merino. The network helps show where Natalia Ramírez-Merino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Natalia Ramírez-Merino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 3 | |
| 4 | 2013 | 121 | |
| 5 | 2011 | 52 | |
| 6 | 2011 | 151 | |
| 7 | 2010 | 22 |
About Natalia Ramírez-Merino
Natalia Ramírez-Merino is a scholar working on Health Information Management, Pharmacy and Oncology, having authored 7 papers that have together received 361 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), DNA Repair Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer Treatment and Pharmacology (2 papers), PARP inhibition in cancer therapy (2 papers), Clinical practice guidelines implementation (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (236 citations), Cancer Research (60 citations) and Surgery (107 citations). Natalia Ramírez-Merino has collaborated with scholars based in Spain, Palestinian Territory and United Kingdom. Frequent co-authors include Federico Rojo, Pîlar Eroles, Joan Albanell, Sònia Servitja, Jetzabel García-Parra, Jaime Ferrer-Lozano, José Yélamos, Sandra Zazo, Cristina Chamizo and Aňa Lluch. Their work appears in journals such as International Journal of Molecular Sciences, Annals of Oncology and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.